| Patients without CAD (n = 24) | Patients with CAD (n = 31) | p value |
---|---|---|---|
Anthropometric characteristics | Â | Â | Â |
Males (%) | 16 (67) | 30 (97) | 0.009 |
Age (years) | 57.6 ± 7.7 | 60.2 ± 8.5 | 0.249 |
BMI (Kg/m2) | 28.5 ± 2.5 | 29.1 ± 2.6 | 0.340 |
Waist to hip ratio | 0.93 ± 0.06 | 1 ± 0.06 | <0.001 |
Metabolic characteristics | Â | Â | Â |
LDL-cholesterol (mmol/L) | 3.41 ± 0.88 | 3.12 ± 0.72 | 0.260 |
HDL-cholesterol (mmol/L) | 1.27 ± 0.28 | 1.11 ± 0.25 | 0.078 |
Triglycerides (mmol/L) | 1.31 ± 0.45 | 1.59 ± 0.15 | 0.231 |
Systolic BP (mmHg) | 123.5 ± 16.4 | 128.4 ± 12.3 | 0.228 |
Diastolic BP (mmHg) | 76.5 ± 9.8 | 79.6 ± 6.8 | 0.176 |
Adiponectin (μg/ml) | 13.8 ± 5.8 | 10.9 ± 3.1 | 0.033* |
Indices | Â | Â | Â |
HOMA index | 3.52 ± 1.84 | 5.17 ± 4.78 | 0.102* |
Matsuda index | 2.90 ± 1.14 | 2.28 ± 1.0 | 0.041 |
Common carotid IMT (mm) | 0.86 ± 0.25 | 1.10 ± 0.30 | 0.004 |
Carotid bulb IMT (mm) | 1.14 ± 0.75 | 1.49 ± 0.48 | 0.062 |
Drug use | Â | Â | Â |
Statins (%) | 9 (38) | 25 (81) | 0.003 |
Antiplatelets (%) | 8 (33) | 27 (87) | <0.001 |
ACE inhibitor, AR antagonists (%) | 9 (38) | 25 (81) | 0.003 |
Nitrates (%) | 3 (13) | 13 (42) | 0.037 |
β-blockers (%) | 5 (21) | 21 (68) | 0.001 |
Calcium channel blockers (%) | 3 (13) | 7 (23) | 0.543 |
Sulfonylureas (%) | 0 (0) | 4 (13) | 0.192 |
Metformin (%) | 1 (4) | 5 (16) | 0.329 |